KetaMD
KetaMD.com is a premium .com domain listed for sale on the Atom.com marketplace, marketed to ketamine-therapy, telemedicine, and pharmaceutical-brand buyers at $3,699 or via lease-to-own. The source data contains no evidence of an operating business, management, funding, or revenue behind the name.
- Company typePrivate
- Founded2020
- HeadquartersMiami Beach, United States
- Headcount11–50
- GTM typeB2B
- OfferingDigital Commerce or Content
What KetaMD does
KetaMD.com is a premium .com domain name currently offered for sale on the Atom.com marketplace. The domain is listed at $3,699 for outright purchase, or via a lease-to-own arrangement requiring a $370 down payment followed by $111 per month for 36 months (total $4,366). Atom's listing characterizes the name as a six-letter, two-syllable brand combining 'Keta' (ketamine) with 'MD' (medical doctor), and positions it for healthcare and mental-health startups, medical clinics, pharmaceutical companies, and telemedicine platforms seeking a credible, memorable web identity in the ketamine therapy category.
The buyer profile targeted by the listing is narrow by design: startups in healthcare and mental health, medical/telemedicine operators, and pharmaceutical companies that need a defensible brand identity. According to the listing, the offering includes verified ownership, immediate transfer capability, Atom's purchase guarantee, and 8+ shortlisted buyers — signals that indicate above-average marketplace demand for this category of name. Pricing is structured to maximize conversion to small-company domain buyers rather than enterprise procurement cycles.
The source data contains no evidence that KetaMD operates as a business. There is no management team, founding year, funding history, employee count, revenue figure, customer list, partnership, product launch, certification, regulatory action, or geographic footprint. All contact information on file routes to Atom.com's general support ([email protected] and +1 847-597-0044), confirming that what is being transacted is a digital-real-estate asset on a domain marketplace — not an operating company. Any firmographic profile attributes (for-profit status, 2020 founding, 11–50 employees, Miami Beach) lack corroborating detail in the source material and should be treated as unverified until substantiated through direct management dialogue.
KetaMD firmographics
Firmographics- Name
- KetaMD
- Legal name
- KetaMD
- Website
- https://ketamd.com
- Company type
- Private
- Founded year
- 2020
- Headcount range
- 11–50 employees
- Short description
- KetaMD.com is a premium .com domain listed for sale on the Atom.com marketplace, marketed to ketamine-therapy, telemedicine, and pharmaceutical-brand buyers at $3,699 or via lease-to-own. The source data contains no evidence of an operating business, management, funding, or revenue behind the name.
- Ownership category
- akta.pro rank
KetaMD industry classification
Industry- Product category
- Premium Domain Name Sales
- NAICS
- Software Publishers (5132)
- akta.pro primary industry
- Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused) (HLALAIAM)
- akta.pro secondary industry
- Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)
Keywords
Where KetaMD is headquartered
LocationHeadquarters
- HQ city
- Miami Beach
- HQ country
- United States
- HQ region
- North America
Markets served
KetaMD business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Operations, Marketing or Sales
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Buy Now - One-time purchase at $3,699 |
| Other | Monthly | Lease to Own - $111/month for 36 months |
KetaMD product offering
Product offeringCore offering
KetaMD is offered as a premium, six-letter, two-syllable .com domain name that combines "Keta" (ketamine) with "MD" (medical doctor). The domain is sold (or leased-to-own) via the Atom.com marketplace and is positioned as a brandable identity for healthcare, mental-health, ketamine-therapy, telemedicine, or pharmaceutical ventures. No operating product, service, or technology platform is associated with the name beyond the domain itself.
Product overview
KetaMD.com is a single premium domain name being offered for sale. The domain is a short, memorable 6-letter, 2-syllable name combining 'Keta' (referencing ketamine) and 'MD' (medical doctor). It is positioned as an ideal brand identity for startups in the healthcare industry, particularly those in mental health, ketamine therapy, telemedicine, or holistic medicine sectors. The offering includes the domain name only, with no associated product services or technology platform.
Differentiator
Problem solved
Functional benefit
Products and services
- KetaMD.com Premium Domain A six-letter, two-syllable premium .com domain name that combines "Keta" (ketamine) and "MD" (medical doctor), available for one-time purchase or lease-to-own through Atom.com. It is positioned as a brandable web address for healthcare, mental-health, ketamine-therapy, telemedicine, or pharmaceutical ventures.
Companies that use KetaMD
Customer profileSegments2 records
Ideal customer profiles2 records
KetaMD technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
KetaMD competitors and assessment
Company assessmentDirect peers
- Nue Life: Telehealth platform offering at-home ketamine-assisted therapy with clinician oversight; the closest direct comparator in the ketamine telemedicine category.
- Wondermed: Ketamine telemedicine platform connecting patients with clinicians for at-home treatments under medical guidance — directly comparable positioning to the firmographic description of KetaMD.
- Mindbloom: Leading U.S. at-home ketamine therapy telemedicine platform and the operational archetype the KetaMD brand would aspire to; same product category (at-home ketamine treatment) and target patient base.
Broad incumbents
- Compass Pathways: Public company developing psilocybin therapy for treatment-resistant depression; a broad incumbent shaping the regulatory and clinical psychedelic-medicine market.
- Field Trip Health: Clinic-based psychedelic-therapy operator (ketamine, psilocybin) with a broader footprint; comparable in category though delivered via clinics rather than at-home telemedicine.
- MindMed: Public psychedelic-medicine biotech advancing LSD and MDMA-assisted therapies; an incumbent in the same psychedelic therapeutics category.
Emerging players
- Joyous: Telehealth ketamine protocol provider at smaller scale than the leaders; relevant emerging player in the same treatment modality.
- Cerebral: Mental-health telemedicine platform; adjacent in telemedicine infrastructure, workflow, and mental-health patient base even though not ketamine-focused.
- Done Global: Direct-to-consumer telemedicine platform for ADHD treatment and controlled-substance prescribing; adjacent on the controlled-substance e-prescribing axis relevant to ketamine telemedicine.
- BetterU: Mental-health telemedicine operator with overlap into ketamine-adjacent treatment programs; comparable as an adjacent emerging digital-mental-health platform.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks6 records
Key highlights5 records
Customer concentration
KetaMD social profiles
Digital presenceKetaMD financial estimates
Financial estimateRevenue estimate
Valuation estimate
KetaMD leadership team
Management profileNumber of profiles
KetaMD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KetaMD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KetaMD
What does KetaMD do?
KetaMD is offered as a premium, six-letter, two-syllable .com domain name that combines "Keta" (ketamine) with "MD" (medical doctor). The domain is sold (or leased-to-own) via the Atom.com marketplace and is positioned as a brandable identity for healthcare, mental-health, ketamine-therapy, telemedicine, or pharmaceutical ventures. No operating product, service, or technology platform is associated with the name beyond the domain itself.
When was KetaMD founded?
KetaMD was founded in 2020. It employs 11 to 50 people.
Where is KetaMD based?
KetaMD is headquartered in Miami Beach, United States, in the North America region.
Who are KetaMD's main competitors?
Direct peers on record are Nue Life, Wondermed and Mindbloom. Broad incumbents are Compass Pathways, Field Trip Health and MindMed. Emerging players are Joyous, Cerebral, Done Global and BetterU.
Does KetaMD have an API?
No public API is recorded for KetaMD.
What industry is KetaMD in?
KetaMD's product category is Premium Domain Name Sales. Its primary akta.pro industry code is HLALAIAM, Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused), with a secondary code of HLAIACAC, Neurology & CNS Specialty Pharmaceuticals. Its NAICS code is 5132.